Endothelial dysfunction in patients with obstructive sleep apnoea independent of metabolic syndrome
Babak Amra1, Elaheh Karbasi, Mohammad Hashemi
1Isfahan University of Medical Sciences, Sheikh Mofid St 8164763831, Isfahan, Iran. amra@med.mui.ac.ir
Introduction:
Obstructive sleep apnoea syndrome (OSAS), characterised by intermittent hypoxia/re-oxygenation, has been identified as an independent risk factor for cardiovascular diseases and endothelial dysfunction. Our aim was to investigate flow-mediated dilatation (FMD) in patients with obstructive sleep apnoea with and without metabolic syndrome.
Materials And Methods:
Fifty-two subjects with OSAS diagnosed by polysomnography were classified into 2 groups according to the presence and absence of the metabolic syndrome and also according to the severity: mild to moderate OSAS group and severe OSAS group. Endothelial function of the brachial artery was evaluated by using high-resolution vascular ultrasound. Endothelial-dependent dilatation (EDD) was assessed by establishing reactive hyperaemia and endothelial-independent dilatation (EID) was determined by using sublingual isosorbide dinitrate. Spearman correlation and regression analysis were performed.
Results:
EDD was not significantly different in patients with OSAS and metabolic syndrome as compared with OSAS without metabolic syndrome (4.62 +/- 0.69 versus 4.49 +/- 0.93, P >0.05).
Conclusions:
Endothelial dysfunction in OSA may be independent of metabolic syndrome.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Coronary Artery Disease I: Introduction
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Heart Failure VI: Adjunct Therapies
Hypertension II: Pathophysiology
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

